Targeting NAD metabolism to treat systemic sclerosis
Description: NARRATIVE Fibrosis in multiple organs in systemic sclerosis is poorly understood, and lacks effective treatment. Based on recently uncovered parallels between the biological pathways driving cellular aging and SSc fibrosis, this R21 will test the novel hypothesis that in SSc NAD+ depletion and compromised SIRT function explain persistent myofibroblast activation and fibrosis, and can be selectively targeted for therapy.
Funding type: research
Funder scheme: R21
Start date: 2018-09-18
End date: 2020-08-31
Investigator: EDUARDO N CHINI (lead)
Institutions: Northwestern University, NORTHWESTERN UNIVERSITY AT CHICAGO
Subfield: Rheumatology
Field: Medicine
Domain: Health Sciences
Funded outputs count: 10
Funder award ID: R21AR074523
OpenAlex ID: G7871017385
